Canaccord Genuity Starts Blueprint Medicines (BPMC) at Buy

August 5, 2016 6:55 AM EDT
Get Alerts BPMC Hot Sheet
Price: $31.70 +2.16%

Rating Summary:
    5 Buy, 1 Hold, 0 Sell

Rating Trend: Up Up

Today's Overall Ratings:
    Up: 26 | Down: 29 | New: 38
Trade BPMC Now!
Join SI Premium – FREE

News and research before you hear about it on CNBC and others. Claim your 2-week free trial to StreetInsider Premium here.

Canaccord Genuity initiated coverage on Blueprint Medicines (NASDAQ: BPMC) with a Buy rating and a price target of $26.00.

For an analyst ratings summary and ratings history on Blueprint Medicines click here. For more ratings news on Blueprint Medicines click here.

Shares of Blueprint Medicines closed at $21.95 yesterday.

Serious News for Serious Traders! Try Premium Free!

You May Also Be Interested In

Related Categories

New Coverage

Related Entities

Canaccord Genuity

Add Your Comment